Rabeprazole: Proton Pump Inhibitor for Acid-Related Disorders

What is Rabeprazole?

Rabeprazole is a prescription medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It works by significantly reducing the amount of acid produced in the stomach, making it effective for treating various acid-related digestive conditions. Rabeprazole is commonly prescribed for gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions where excess stomach acid causes symptoms or damage.

Uses

Rabeprazole is approved for several digestive conditions:

Gastroesophageal reflux disease (GERD): Treats heartburn and acid reflux by reducing stomach acid production, allowing the esophagus to heal from acid damage.

Peptic ulcers: Helps heal stomach and duodenal ulcers by creating a less acidic environment that promotes healing and reduces pain.

Submit Your Paper

Zollinger-Ellison syndrome: Manages this rare condition where tumors cause excessive acid production in the stomach.

Helicobacter pylori eradication: Used in combination with antibiotics to eliminate H. pylori bacteria, a common cause of peptic ulcers.

Erosive esophagitis: Treats inflammation and erosion of the esophagus caused by stomach acid backing up into the esophagus.

How it works

Rabeprazole blocks the final step in stomach acid production by inhibiting the hydrogen-potassium ATPase enzyme system, also known as the proton pump. This pump is located in the acid-producing cells of the stomach lining and is responsible for releasing acid into the stomach. By blocking this pump, rabeprazole can reduce stomach acid production by up to 90%, providing significant relief from acid-related symptoms and allowing damaged tissues to heal.

Side effects

Common side effects include:

• Headache
• Diarrhea
• Nausea
• Abdominal pain
• Constipation
• Flatulence
• Dizziness
• Dry mouth

Serious side effects to watch for:

• Severe allergic reactions with rash, swelling, or difficulty breathing
• Clostridioides difficile-associated diarrhea (CDAD)
• Bone fractures, particularly in the hip, wrist, or spine with long-term use
• Low magnesium levels causing muscle spasms, irregular heartbeat, or seizures
• Severe skin reactions such as Stevens-Johnson syndrome

Warnings and precautions

Long-term use considerations: Extended use of rabeprazole may increase the risk of bone fractures, vitamin B12 deficiency, and low magnesium levels. Regular monitoring may be necessary for patients on long-term therapy.

Pregnancy and breastfeeding: Rabeprazole is classified as pregnancy category B, meaning animal studies have not shown risk to the fetus, but adequate human studies are lacking. It should only be used during pregnancy if clearly needed.

Kidney and liver function: Patients with severe liver impairment may need dose adjustments, though no dosage adjustment is typically necessary for kidney problems.

Infection risk: PPIs like rabeprazole may increase the risk of certain infections, including pneumonia and intestinal infections, by reducing stomach acid that normally helps kill harmful bacteria.

Gastric malignancy: Treatment with rabeprazole may mask symptoms of gastric cancer, so malignancy should be ruled out before starting therapy, especially in patients with alarm symptoms.

Interactions

Warfarin: Rabeprazole may increase warfarin levels, potentially increasing bleeding risk and requiring more frequent monitoring of blood clotting times.

Atazanavir and nelfinavir: These HIV medications require stomach acid for proper absorption, and rabeprazole may significantly reduce their effectiveness.

Clopidogrel: Rabeprazole may reduce the antiplatelet effects of clopidogrel, potentially increasing cardiovascular risks in some patients.

Digoxin: Reduced stomach acid may increase digoxin absorption, potentially leading to elevated digoxin levels and toxicity.

Ketoconazole and itraconazole: These antifungal medications need acidic conditions for absorption and may be less effective when taken with rabeprazole.

Iron supplements: Rabeprazole may reduce iron absorption, potentially affecting treatment of iron deficiency anemia.

Methotrexate: PPIs may increase methotrexate levels, particularly at high doses, increasing the risk of methotrexate toxicity.

Check interactions with the GMJ Interaction Checker

Dosage

GERD treatment: The typical adult dose is 20 mg once daily for 4-8 weeks. For maintenance therapy, 20 mg once daily may be continued.

Peptic ulcer disease: Usually 20 mg once daily for 4-8 weeks, depending on the location and severity of the ulcer.

H. pylori eradication: 20 mg twice daily for 7 days in combination with appropriate antibiotics.

Zollinger-Ellison syndrome: Starting dose is typically 60 mg once daily, with adjustments based on individual response and acid output measurements.

All dosages should be determined by a healthcare provider based on the specific condition being treated, patient response, and individual medical factors. Rabeprazole is typically taken before meals for optimal effectiveness.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).